IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 24, 2018

Primary Completion Date

July 7, 2019

Study Completion Date

November 30, 2020

Conditions
Abdominal Wall HerniaPancreatic DiseasesBowel DiseaseGastric Disease
Interventions
DRUG

Acetaminophen Injectable Product

The interventional group will receive 1 gram intravenous acetaminophen at the start of wound closure to be repeated every 6 hours for 48 hours postoperatively

DRUG

Sodium Chloride 0.9%, Intravenous

The placebo group will be given an intravenous placebo of saline solution at wound closure and repeated every 6 hours for 48 hours postoperatively.

Trial Locations (1)

15213

Upmc Presbyterian Montefiore Hospital, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Kathirvel Subramaniam

OTHER